Sá-Correia I, Fialho A M, Videira P, Moreira L M, Marques A R, Albano H
Centro de Engenharia Biológica e Química, Instituto Superior Técnico, Lisbon 1049-001, Portugal.
J Ind Microbiol Biotechnol. 2002 Oct;29(4):170-6. doi: 10.1038/sj.jim.7000266.
The commercial gelling agent, gellan, is an extracellular polysaccharide (EPS) produced by Sphingomonas paucimobilis ATCC 31461. In recent years, significant progress in understanding the relationship between gellan structure and properties and elucidation of the biosynthesis and engineering of this recent product of biotechnology has been made. This review focuses on recent advances in this field. Emphasis is given to identification and characterization of genes and enzymes involved, or predicted to be involved, in the gellan biosynthetic pathway, at the level of synthesis of sugar-activated precursors, of the repeat unit assembly and of gellan polymerization and export. Identification of several genes, biochemical characterization of the encoded enzymes and elucidation of crucial steps of the gellan pathway indicate that possibilities now exist for exerting control over gellan production at any of the three levels of its biosynthesis. However, a better knowledge of the poorly understood steps and of the bottlenecks and regulation of the pathway, the characterization of the composition, structure and functional properties of gellan-like polymers produced either by the industrial strain under different culture conditions or by mutants are still required for eventual success of the metabolic engineering of gellan production.
商业化的胶凝剂结冷胶是由少动鞘氨醇单胞菌ATCC 31461产生的一种胞外多糖(EPS)。近年来,在理解结冷胶结构与性能之间的关系以及阐明这种最新生物技术产品的生物合成与工程方面取得了重大进展。本综述聚焦于该领域的最新进展。重点在于参与或预计参与结冷胶生物合成途径的基因和酶的鉴定与表征,涉及糖激活前体的合成、重复单元组装以及结冷胶聚合和输出的层面。多个基因的鉴定、所编码酶的生化特性表征以及结冷胶途径关键步骤的阐明表明,现在有可能在其生物合成的三个层面中的任何一个层面上对结冷胶的生产进行控制。然而,为了结冷胶生产代谢工程最终取得成功,仍需要更深入了解那些理解不足的步骤以及该途径的瓶颈和调控,还需要对工业菌株在不同培养条件下或突变体所产生的类似结冷胶聚合物的组成、结构和功能特性进行表征。